Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells

Autor: Wang, Yao a, 1, Zhang, Wen-ying b, 1, Han, Qing-wang a, 1, Liu, Yang c, Dai, Han-ren a, Guo, Ye-lei a, Bo, Jian d, Fan, Hui b, Zhang, Yan b, Zhang, Ya-jing b, Chen, Mei-xia b, Feng, Kai-chao b, Wang, Quan-shun d, Fu, Xiao-bing a, Han, Wei-dong a, ⁎
Zdroj: In Clinical Immunology December 2014 155(2):160-175
Databáze: ScienceDirect
Externí odkaz: